Oncological Therapies Applications
-
Premium
Track-Etched Polymer Membrane Filters for Diagnostics
Recovery of cervical cancer cells and isolation of circulating rare cells, detection and counting of bacteria recovered from food, beverage or cosmetics (flow cytometry, fluorescence microscopy), detection and analysis of recovered airborne particles (asbestos, AOX), ...
By it4ip S.A. based in Louvain-la-Neuve, BELGIUM.
-
Ceritinib
This active molecular is a selective inhibitor of ALK(anaplastic lymphoma kinase)which is a target found in NSCLC (metastatic non-small cell lung cancer).https://www.bocsci.com/ceritinib-cas-1032900-25-6-item-462148.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
TCB001 ImmuniCell Clinical Trial
This trial investigated the safety profile of large numbers of GDT cells derived from patients and was open to certain patients with skin, kidney or lung cancers. This trial is now closed. ...
By TC BioPharm based in Holytown, UNITED KINGDOM.
-
Pexidartinib (PLX3397)
Pexidartinib (PLX3397) is an oral, potent mutil-targeted receptor tyrosine kinase inhibitor of CSF-1R with IC50 of 20 nM, Kit with IC50 of 10 nM, and Flt3 with IC50 160 nM. https://www.bocsci.com/pexidartinib-plx3397-cas-1029044-16-3-item-470807.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
PTR-MS systems for medical applications
PTR-MS are powerful tools for non-invasive, real-time breath gas analysis with many applications, such as screening for disease markers, study of pharmacokinetics or metabolic ...
By Ionicon Analytik Ges.m.b.H. based in Innsbruck, AUSTRIA.
-
TP508 & Covid-19
There remains a critical need for a therapeutic to be used in combination with antivirals to prevent COVID-19 progression and reduce post-recovery complications. SARS-CoV-2-induces a “cytokine storm” in the lungs and causes vascular damage throughout the body. Viral infection and cytokine-induced vascular damage initiate intravascular coagulation that leads to multiple organ failure and post-recovery damage to the brain and heart. Thus, COVID-19 is now recognized as an endothelial dysfunction-related ...
By Chrysalis BioTherapeutics, Inc. based in Galveston, TEXAS (USA).
-
RNA Technology for Product Pipeline Research
Our product pipeline shows the progress we’re making on clinical programs currently in development to create mRNA medicines for a wide range of diseases and conditions. We are proud of the advancements we’ve made in pioneering new mRNA vaccines and treatments that may have the potential to treat and prevent rare ...
By Moderna, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Partial Mastectomy - How MarginProbe® Can Help
Partial mastectomy is another name for a lumpectomy, a breast-conserving surgery that only removes the part of the breast that has cancer and a small rim around it to help prevent ...
By Dilon Technologies Inc. based in Newport News, VIRGINIA (USA).
-
Proprietary Technologies for Approach Towards Cancer
With the development and commercialization of immunotherapy drugs such as checkpoint inhibitors, the field of immuno-oncology is transforming the treatment of patients with cancer. However, cures remain elusive, and many cancer patients experience only modest clinical ...
By Gritstone Bio based in Emeryville, CALIFORNIA (USA).
-
Isotopes for Medical
One of the principal uses of medical isotopes is for diagnostic imaging procedures in the human body. Radioactive isotopes such as technetium-99m (Tc-99m), a daughter isotope of Mo-99, are light-producing elements used in nuclear medicine imaging. When introduced into the patient’s body for medical diagnostic procedures, these radioisotopes help doctors examine how their patients’ various tissues and internal organs are functioning. Some examples of diagnostic nuclear medicine include imaging coronary ...
By Shine Technologies based in Janesville, WISCONSIN (USA).
-
Zenalux Technology in Pre-clinical and Clinical Applications
Zenalux technology has been applied to the quantitative optical analysis of tissues in a number of published studies in both pre-clinical models and in patients. In the breast, the Zenalux technology has been proven to be sensitive to sources of intrinsic optical contrast, in particular, hemoglobin, beta carotene and scattering which effectively discriminate diseased from healthy tissues (see Published Papers.) ...
By Zenalux Biomedical, Inc. based in Durham, NORTH CAROLINA (USA).
-
Optical coherence tomograph solutions for general clinica sector
VivoSight Dx produces high resolution imaging and measurement of skin sub-structures and vascular networks to aid in patient ...
By Michelson Diagnostics Ltd. (MDL) based in Maidstone, UNITED KINGDOM.
-
Immunoscore for IC in Lung Cancer
IMMUNOSCORE® IC is intended for the detection of PD-L1 protein and the concomitant detection of CD8 + cells in Non-Small Cell Lung cancer (NSCLC) ...
By Veracyte based in Marseille Cedex 9, FRANCE.
-
Personal ECG device solutions for biopharma sector
Leverage customizable digital health solutions to provide patient heart rhythm data, anytime and ...
By AliveCor, Inc based in Mountain View, CALIFORNIA (USA).
-
Indications LLLT Application
The low level laser therapy is successfully used in nearly all areas of medicine. Numerous studies and long-term clinical experiences substantiate the efficacy of the low level laser ...
By Heltschl Medizintechnik GmbH based in Schlüsslberg, AUSTRIA.
-
Highly customized aptamer discovery solutions for hot areas for aptamers sector
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
BSD-2000 - Deep Regional Hyperthermia System for Clinical
Randomized clinical trials (RCT’s) have been shown significant improvement in clinical outcome when hyperthermia was added to radiotherapy and/or chemotherapy. In 2004 experts in clinical hyperthermia held a consensus meeting (Kadota Fund International Forum 2004) about the evidence of the published clinical results of the RCT’s. Level 1 evidence was found for bladder cancer, breast cancer, cervical cancer, cancer of the esophagus, lymph nodes of head and neck tumors, rectum cancer, soft tissue ...
By Pyrexar based in Salt Lake City, UTAH (USA).
-
Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
For surgical oncologists, Mobetron serves a critical collaborative role in efficiently and effectively delivering an ablative dose of radiation directly to the tumor bed at the optimal biological time. It ensures confidence among surgical specialists that microscopic and residual cancers have been effectively ...
By IntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA).
-
Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
For the world’s leading radiation oncologists, cancer treatment has changed dramatically in recent years. Electron beam technology is becoming more precise, more portable and more efficient. And the interaction and collaboration with surgical teams in the OR has meant that radiation treatment has entered a new era. An era where the procedure is successfully administered in ...
By IntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA).
-
NBS - Navigated Brain Stimulation System for Radiotherapy
For patients undergoing radiotherapy for brain metastases, it is important to preserve quality of life after a course of therapy. As a non-invasive method, SmartFocus® nTMS mapping is a valuable new tool for radiotherapists to accurately and reliably modify dosing to help preserve motor function and potentially the quality of life of their ...
By Nexstim Plc based in Helsinki, FINLAND.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you